edoc

Items where Author is "Joerger, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Refereed
Jump to: 2016 | 2014 | 2013 | 2012 | 2011 | 2010 | 2008
Number of items: 12.

2016

Neumair, P. and Joos, L. and Warschkow, R. and Dutly, A. and Ess, S. and Hitz, F. and Fruh, M. and Brutsche, M. and Baty, F. and Krahenbuhl, S. and Cerny, T. and Joerger, M.. (2016) Erlotinib has comparable clinical efficacy to chemotherapy in pretreated patients with advanced non-small cell lung cancer (NSCLC): A propensity-adjusted, outcomes research-based study. Lung Cancer, 100. pp. 38-44.

2014

Joerger, M. and Schaer-Thuer, C. and Koeberle, D. and Matter-Walstra, K. and Gibbons-Marsico, J. and Diem, S. and Thuerlimann, B. and Cerny, T.. (2014) Off-label use of anticancer drugs in eastern Switzerland: a population-based prospective cohort study. European Journal of Clinical Pharmacology, 70 (6). p. 719.

2013

Mueller, F. and Büchel, B. and Köberle, D. and Schürch, S. and Pfister, B. and Krähenbühl, St and Froehlich, T. K. and Largiader, C. R. and Joerger, M.. (2013) Gender-specific elimination of continuous-infusional 5-fluorouracil in patients with gastrointestinal malignancies: results from a prospective population pharmacokinetic study. Cancer chemotherapy and pharmacology, Vol. 71, H. 2. pp. 361-370.

Joerger, M. and Thürlimann, B. and Savidan, A. and Frick, H. and Rageth, C. and Lütolf, U. and Vlastos, G. and Bouchardy, C. and Konzelmann, I. and Bordoni, A. Probst-Hensch and Jundt, G. and Ess, S.. (2013) Treatment of breast cancer in the elderly : a prospective, population-based Swiss study. Journal of geriatric oncology, Vol. 4, H. 1. pp. 39-47.

2012

Joerger, M. and Thürlimann, B. and Savidan, A. and Frick, H. and Bouchardy, C. and Konzelmann, I. and Probst-Hensch, N. and Ess, S.. (2012) A population-based study on the implementation of treatment recommendations for chemotherapy in early breast cancer. Clinical breast cancer, Vol. 12, H. 2. pp. 102-109.

Joerger, M. and Ferreri, A. J. M. and Krähenbühl, S. and Schellens, J. H. M. and Cerny, Th and Zucca, E. and Huitema, A. D. R.. (2012) Dosing algorithm to target a predefined AUC in patients with primary central nervous system lymphoma receiving high dose methotrexate. British journal of clinical pharmacology, Vol. 73, H. 2. pp. 240-247.

2011

Joerger, M. and Riesen, W. F. and Thürlimann, B.. (2011) Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer. Journal of oncology pharmacy practice, Vol. 17, H. 3. pp. 292-294.

Ess, S. and Joerger, M. and Frick, H. and Probst-Hensch, N. and Vlastos, G. and Rageth, C. and Lütolf, U. and Savidan, A. and Thürlimann, B.. (2011) Predictors of state-of-the-art management of early breast cancer in Switzerland. Annals of oncology, Vol. 22, H. 3. pp. 618-624.

Joerger, M. and Templeton, A. and Köberle, D. and Engler, H. and Riesen, W. F. and Thürlimann, B.. (2011) Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates. Cancer chemotherapy and pharmacology, Vol. 67, H. 5. pp. 1137-1144.

Joerger, M. and Thürlimann, B. and Huober, J.. (2011) Small HER2-positive, node-negative breast cancer : who should receive systemic adjuvant treatment? Annals of oncology, Vol. 22. pp. 17-23.

2010

Joerger, M. and Huitema, A. D. R. and Krähenbühl, S. and Schellens, J. H. M. and Cerny, T. and Reni, M. and Zucca, E. and Cavalli, F. and Ferreri, A. J. M.. (2010) Methotrexate area under the curve is an important outcome predictor in patients with primary CNS lymphoma : a pharmacokinetic-pharmacodynamic analysis from the IELSG no. 20 trial. British journal of cancer, Vol. 102, H. 4. pp. 673-677.

2008

Joerger, M. and Nuessli, D. F. and Henz, S. and Zaunbauer, W. and Cerny, T. and Cogliatti, S. B. and Gillessen, S.. (2008) CT-diagnosed mesenteric alterations in patients with non-Hodgkin's lymphoma: a population-based study. Onkologie, 31 (10). pp. 514-519.

This list was generated on Thu Mar 28 14:33:28 2024 CET.